Lynx1 Capital Management Lp's Net Worth
Lynx1 Capital Management Lp's net worth is estimated to be at least $4,316,427.84 as of 08/11/2025. CoreStreet's estimation of Lynx1 Capital Management Lp's net worth is based on their sale of stock and current holding of stock.
Lynx1 Capital Management Lp is Major Shareholder at Passage Bio Inc. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 66,423 units of PASG stock on 07/24/2025. Their biggest sale was on 05/31/2023 when they sold 25,400 units of Tscan Therapeutics Inc stock for $64,008.00. They typically trade 3 times per year.
Total value of insider buys:
- $4,252,419.84
Total value of insider sells:
- $64,008.00
Most recent insider trade:
- July 24, 2025
Lynx1 Capital Management Lp's Insider Trading History
| Passage Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 24, 2025 | Major Shareholder | 66,423 | $5.71 | Buy | $379,275.33 |
July 23, 2025 | Major Shareholder | 49,302 | $5.74 | Buy | $282,993.48 |
July 22, 2025 | Major Shareholder | 13,123 | $5.44 | Buy | $71,389.12 |
Dec. 27, 2024 | Major Shareholder | 373,645 | $0.65 | Buy | $242,869.25 |
Nov. 27, 2024 | Major Shareholder | 29,300 | $0.67 | Buy | $19,631.00 |
Nov. 25, 2024 | Major Shareholder | 259,998 | $0.56 | Buy | $145,598.88 |
| Tscan Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 20, 2025 | Major Shareholder | 1,200,000 | $1.20 | Buy | $1,440,000.00 |
May 19, 2025 | Major Shareholder | 1,388,794 | $1.20 | Buy | $1,666,552.80 |
Nov. 15, 2024 | Major Shareholder | 947 | $4.34 | Buy | $4,109.98 |
May 31, 2023 | Major Shareholder | 25,400 | $2.52 | Sell | $64,008.00 |